Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | 1,095,009 | reported | 23 Jun 2004 | tx 64+200,791−239,091 |
| Vir Biotechnology, Inc. | 1,078,391 | reported | 01 May 2026 | tx 67+212,554−685,279 |
| Allogene Therapeutics, Inc. | 144,400 | reported | 18 Jun 2025 | tx 9+492,967 |
| Denali Therapeutics Inc. | 107,976 | reported | 02 Jan 2025 | tx 65+256,150−113,520 |
| BRISTOL MYERS SQUIBB CO | 75,689.43 | reported | 01 Feb 2021 | tx 23+58,013.77 |
| REVVITY, INC. | 38,278 | reported | 09 Feb 2017 | tx 57+197,800−149,884 |
| BORGWARNER INC | 19,823.19 | reported | 29 Apr 2020 | tx 8+22,163 |
| ALNYLAM PHARMACEUTICALS, INC. | 15,000 | reported | 02 Jun 2010 | tx 4+60,000 |
| Syros Pharmaceuticals, Inc. | 11,000 | reported | 11 Jun 2019 | tx 5+66,000 |
| DISCOVERY PARTNERS INTERNATIONAL INC | 1,875 | reported | 22 May 2008 | tx 8+69,746 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | SALE | Vir Biotechnology, Inc. | 22,000 | 10.05 USD | 10b5-1 |
| 02 Mar 2026 | SALE | Vir Biotechnology, Inc. | 200 | 9.98 USD | |
| 02 Mar 2026 | SALE | Vir Biotechnology, Inc. | 21,800 | 9.50 USD | |
| 24 Feb 2026 | EXERCISE | Vir Biotechnology, Inc. | 42,377 | 1.49 USD | |
| 24 Feb 2026 | SALE | Vir Biotechnology, Inc. | 42,177 | 9.75 USD | |
| 24 Feb 2026 | SALE | Vir Biotechnology, Inc. | 200 | 10.26 USD | |
| 24 Feb 2026 | EXERCISE | Vir Biotechnology, Inc. | 42,377 | 0.00 USD | deriv |
| 02 Feb 2026 | SALE | Vir Biotechnology, Inc. | 22,000 | 7.71 USD | |
| 02 Jan 2026 | SALE | Vir Biotechnology, Inc. | 22,000 | 5.93 USD | |
| 01 Dec 2025 | SALE | Vir Biotechnology, Inc. | 22,000 | 6.00 USD | |
| 03 Nov 2025 | SALE | Vir Biotechnology, Inc. | 22,000 | 5.64 USD | |
| 01 Oct 2025 | SALE | Vir Biotechnology, Inc. | 22,000 | 5.84 USD | |
| 02 Sept 2025 | SALE | Vir Biotechnology, Inc. | 22,000 | 4.99 USD | |
| 01 Aug 2025 | SALE | Vir Biotechnology, Inc. | 22,000 | 4.99 USD | |
| 01 Jul 2025 | SALE | Vir Biotechnology, Inc. | 22,000 | 5.10 USD | |
| 18 Jun 2025 | GRANT_AWARD | Allogene Therapeutics, Inc. | 144,400 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | Vir Biotechnology, Inc. | 8,000 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 08 Jan 2025 | SALE | Vir Biotechnology, Inc. | 10,960 | 12.52 USD | |
| 02 Jan 2025 | SALE | Denali Therapeutics Inc. | 3,080 | 20.91 USD | |
| 07 Nov 2024 | SALE | Denali Therapeutics Inc. | 1,020 | 30.00 USD | |
| 01 Nov 2024 | SALE | Denali Therapeutics Inc. | 3,080 | 27.07 USD | |
| 13 Sept 2024 | SALE | Denali Therapeutics Inc. | 1,020 | 30.00 USD | |
| 03 Sept 2024 | SALE | Denali Therapeutics Inc. | 2,980 | 24.99 USD | |
| 03 Sept 2024 | SALE | Denali Therapeutics Inc. | 100 | 25.37 USD |